About Epirubicin Hydrochloride
            
            Class: | Anthracycline antibiotic  
Use: | Treatment of various cancers including breast cancer, bladder cancer, and lung cancer; used as part of combination chemotherapy regimens  
Adult dose: | Typically 60-90 mg/m² IV every 3-4 weeks, depending on the specific cancer type and treatment protocol  
Pediatric dose: | 75-90 mg/m² IV every 3-4 weeks; dosing may vary based on specific protocols and patient condition  
Side effects: | Nausea, vomiting, hair loss, myelosuppression (decreased blood ce
         
        
            
                
                
                    
                        Drug Class
                    
                    Anthracycline antibiotic
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of various cancers including breast cancer, bladder cancer, and lung cancer; used as part of combination chemotherapy regimens
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 20-25°C (68-77°F); protect from light; do not freeze; once diluted, use immediately or store at 2-8°C for up to 24 hours
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Mustafa Nevzat Ilac Sanayii A.S., TURKEY
                    
                    
                    Package Size
                    25ml Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 155.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Typically 60-90 mg/m² IV every 3-4 weeks, depending on the specific cancer type and treatment protocol
                    
                    
                        Pediatric Dose
                    
                    
                        75-90 mg/m² IV every 3-4 weeks; dosing may vary based on specific protocols and patient condition
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, hair loss, myelosuppression (decreased blood cell production), cardiotoxicity, mucositis, and injection site reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to epirubicin or any component of the formulation; severe myocardial insufficiency; recent myocardial infarction; severe arrhythmias; pregnancy and breastfeeding
         
        
        
            
                Important Warnings
            
            Risk of cardiotoxicity, especially in patients with pre-existing heart conditions; monitor cardiac function; potential for secondary malignancies; use caution in patients with liver impairment; may cause severe myelosuppression leading to increased risk of infection and bleeding
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.